ABSTRACT
ously we showed that activated platelets interact with endothelium and induce alterations of chemotactic and adhesive properties of endothelial cells, a critical initial step in atherogenesis (2) . We recently demonstrated in vivo that platelets adhere to the vascular endothelium of the carotid artery in ApoE-deficient mice before the development of manifest atherosclerotic lesions (3) . Platelet adhesion to the endothelium coincided with inflammatory gene expression and preceded atherosclerotic plaque invasion by circulating polymorphonuclear cells (3) . Prolonged blockade of platelet adhesion in ApoE-deficient mice profoundly reduced leukocyte accumulation in the arterial intima and attenuated atherosclerotic lesion formation (3, 4) .
Endothelial progenitor cells (EPCs) are increasingly recognized to play a critical role in vascular repair mechanisms and atherogenesis (5) . Platelets are the first circulating blood cells that interact and adhere to vascular lesions (6) . Thus, platelets may be involved in recruitment of circulating progenitor cells toward the injured vessel wall. Recently, we found that platelets stimulate chemotaxis and migration of mouse embryonic endothelial progenitor cells in vitro (7) . Further, murine embryonic EPCs adhered substantially to immobilized platelets under dynamic flow conditions mediated by adhesion receptors PSGL-1/P-selectin, CD18 (␤ 2 -integrin), and VLA4 (␣ 4 /␤ 1 -integrin) (7) . Moreover, activated platelets secrete the chemokine SDF-1␣ and support primary adhesion and migration of progenitor cells in vivo (23) .
EPCs are a circulating, bone marrow-derived cell population of large nonleukocyte cells characterized by the expression of three cell surface markers: CD133, CD34, and vascular endothelial growth factor receptor-2 (VEGFR-2) (8) . EPCs appear to participate in vascular repair and homeostasis. In response to cytokine stimulation and ischemia, these cells are mobilized from the bone marrow, home to the ischemic tissue, and contribute to neovascularization and angiogenesis (9) . Furthermore, EPCs are regarded to have a key role in the maintenance of vascular integrity and to act as "repair" cells in response to endothelial injury (10) . Recruitment of EPCs toward vascular lesions has been regarded as a critical initial step in atherosclerosis and a result of the actions of various cardiovascular risk factors (5) . Current data suggest that a decrease in circulating EPCs leads not only to impaired angiogenesis, but also to the progression of atherosclerosis (11) . Moreover, patients at risk for coronary artery disease have a decreased number of circulating EPCs with impaired activity (12) (13) (14) . Thus, there is increasing evidence that bone marrow-derived progenitor cells play a critical role in vascular repair mechanisms at the site of vascular lesions.
The present study evaluates the effect of platelets on the recruitment and differentiation of human CD34 ϩ progenitor cells and describes a potentially important mechanism of platelet-induced foam cell formation and generation of endothelium in vascular repair mechanisms and atherogenesis.
MATERIALS AND METHODS

Reagents
For adhesion experiments, the function-blocking monoclonal antibodies (mAbs) mouse anti-CD162 (PSGL-1, clone PL1) and mouse anti-CD49d (␣ 4 -integrin, clone HP2/1) were purchased from Immunotech (Marseille, France). Moreover, mouse anti-human CD62P (clone G1/G1-4) and mouse anti-human CD18 (␤ 2 integrin, clone IB4) were bought from Ancell (Bayport, MN, USA). 2D1 (monoclonal antibody, Ab) raised in a rat recognizes an irrelevant human antigen (3) . For immunofluorescence staining, the following antibodies and reagents were used: mouse anti-human CD68 (clone KP1, DakoCytomation, Hamburg, Germany) in combination with Alexa fluor anti-mouse IgG 1 Ab (Invitrogen, Karlsruhe, Germany); a rabbit anti-human polyclonal antibody (pAb) directed against "von Willebrand factor" (vWF, Dako) combined with anti-rabbit IgG-Cy3 (Sigma, Taufkirchen, Germany). 4Ј,6Ј-Diamidino-2-phenylidole (DAPI) (4Ј, 6-diamidino-2-phenylindole dihydrochloride, Sigma) was used to stain cell nuclei. The fluorochrome celltracker tm orange CMTMR (Molecular Probes, Leiden, Netherlands) and DilAcLDL (lipoprotein low density, acetylated human, Bio Trend, Köln, Germany) were used to evaluate platelet and AcLDL phagocytosis. For flow cytometry, fluorescein isothiocyanate (FITC) -labeled antibodies to CD31 (clone 5.6; Beckman Coulter, Krefeld, Germany) and CD146 (clone 128018; R&D Systems, Wiesbaden, Germany) were used. Inhibitors of the HMG coenzyme A reductase (statins)-simvastatin and pravastatin-were both from Merck (Schwalbach, Germany); fluvastatin was from Novartis (Basel, Switzerland) and atorvastatin from Pfizer (Karlsruhe, Germany). The peroxisome proliferator-activated receptor (PPAR) -␣ agonists fenofibrate and WY14643 were purchased from Sigma and from Biomol (Hamburg, Germany), respectively; the PPAR-␥ agonists troglitazone and GW1929 were from Biomol and Alexis Biochemicals (Grü nberg, Germany). Quinacrine dihydrochloride (mepacrine) was used from Sigma. The peptide matrix metalloproteinase (MMP) inhibitor GM6001 was from Calbiochem (San Diego, CA, USA).
Isolation of platelets
Human platelets were isolated as described before (7) . Briefly, venous blood was drawn from healthy volunteers and collected in acid-citrate-dextrose (␣-chlorohydrin) buffer. After centrifugation at 430 g for 20 min, platelet-rich plasma was removed, added to Tyrodes-HEPES buffer [HEPES 2.5 mmol/L, NaCl 150 mmol/L, KCl 1 mmol/L, NaHCO 3 2.5 mmol/L, NaH 2 PO 4 0.36 mmol/L, glucose (Glc) 5.5 mmol/L, BSA 1 mg/ml, pH 6.5] , and centrifugated at 900 g for 10 min. After removal of the supernatant, the resulting platelet pellet was resuspended in Tyrodes-HEPES buffer (pH 7.4). The platelet isolation procedure revealed a high purity of platelets without any measurable contamination of polymorphonuclear cells or monocytes as verified by the absence of CD14 (flow cytometry) and of myeloperoxidase (ELISA).
Isolation, culture, and coincubation of human CD34
؉ cells with isolated platelets
Human CD34
ϩ cells were isolated from human cord blood and cultured as described before (15) . Human cord blood was obtained from healthy women immediately after childbirth with the approval of the local Ethics Committee (Project-No. 76/2005). The isolated cells were Ͼ 98% positive for CD34 ϩ as determined by flow cytometry after each isolation procedure.
Human mononuclear cells were obtained from human umbilical cord blood by density gradient centrifugation on Biocoll separation solution (Biochrom, Berlin, Germany) at 600 g for 15 min. CD34 ϩ cells were enriched by immunoaffinity selection (CD34 Progenitor Cell Isolation Kit; Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. Cells were subsequently incubated on 96-well plates coated with 0.2% gelatin. For cell culture, IMDM with Glutamax supplemented with 5% heat-inactivated fetal calf serum, penicillin (100 U/ml)/streptomycin (100 g/ml), 1% MEM vitamines, and 1% nonessential amino acids, all purchased from Life Technologies, Inc. (Invitrogen), was used. CD34 ϩ progenitor cells (50,000 cells) were cocultured with platelets (2ϫ10 8 /ml) in 96-well plates precoated with 0.2% gelatin at 37°C and 5% CO 2 for 10 days. Developing foam cells were counted in six windows by phase contrast microscopy. To evaluate the effect of statins and PPAR agonists on platelet-dependent foam cell generation, CD34 ϩ progenitor cells were cultured in the presence of platelets and of fluvastatin, simvastatin, atorvastatin, and pravastatin or PPAR agonists in the concentrations indicated.
Determination of MMP-9
matrix metalloproteinase 9 (MMP-9) activity was determined in supernatants by gelatin zymography as described before (16) . SDS gels containing 10% gelatin were from Invitrogen. Equal amounts of supernatants were loaded onto the gels; after electrophoresis, renaturation, and further incubation of the gels for 12 h at 37°C, gelatinolytic activity of MMP-2 and MMP-9 was detected as transparent bands on the Comassie brilliant blue-stained gels.
Platelet adhesion to CD34
؉ progenitor cells under static conditions
To evaluate CD34
ϩ /platelet adhesion under static conditions, isolated platelets (2ϫ10 8 /ml) were allowed to adhere to 96-well plates coated with collagen type I (10 g/ml) for 2 h. Subsequently, CD34
ϩ progenitor cells were added and incubated for 1 h. Unspecific adhesion was prevented by blocking with BSA (2%). After two gentle washing steps with PBS, residual adherent CD34 ϩ progenitor cells were counted by direct phase contrast microscopy. Where indicated, EPCs or immobilized platelets were preincubated for 30 min with mAbs against known EPCs surface adhesion receptors [anti-P-selectin glycoprotein ligand-1 (CD162), anti-␣ 4 (CD49d), and anti-␤ 2 integrins (CD18)] and against platelet P-selectin (anti-CD62P), respectively.
Colony forming assay and flow cytometry
CD34
ϩ progenitor cells were seeded onto human fibronectin (Becton Dickinson, Heidelberg, Germany) or on immobilized platelets (2ϫ10 8 cells/ml) and cultivated for several days in endothelial cell growth medium MV 2 containing 5% heat-inactivated fetal calf serum, 5.0 ng/ml epidermal growth factor (EGF), 0.2 g/ml hydrocortisone, 0.5 g/ml VEGF, 10 ng/ml basic fibroblast factor, 20 ng/ml R3 insulin-like growth factor (IGF) -1, 1 g/ml ascorbic acid (PromoCell, Heidelberg, Germany). After 48 h, nonadherent cells were removed. Endothelial colony-forming units were counted between days 5 and 10 (number of colonies/10 6 cells). Cells were washed and resuspended in PBS, incubated with polyglobin (Bayer Vital, Leverkusen, Germany) for 15 min, washed, and incubated with FITC-labeled antibodies to CD31 (clone 5.6; Beckman Coulter) and CD146 (clone 128018; R&D Systems) for 30 min at room temperature. After washing, cells were analyzed on a FACSCanto flow cytometer (Becton Dickinson).
Immunofluorescence microscopy and cell staining procedures
Immunofluorescence
CD34
ϩ cells were coincubated with medium or platelets for 10 days on chamber slides and processed for immunofluorescence microscopy. Between each incubation step, cells were gently washed with PBS. CD34 ϩ cells were fixed with 2% formaldehyde solution for 20 min. Afterward cells were washed with 2% glycine, permeabilized with 0.2% Triton-X100, and incubated with PBS containing a monoclonal mouse anti-human CD68 Ab (4.7 g/ml) for 1 h. As secondary Ab, an Alexa Fluor anti-mouse IgG 1 Ab (10 g/ml) was added for another hour; finally, DAPI staining (3.3 g/ml) was performed to visualize cell nuclei. Unspecific binding was prevented by BSA (3%, 1 h). Rhodamine phalloidin (5 U/ml, detection of cytoskeletal actin) was applied for 30 min. For labeling, a rabbit anti-human vWF Ab (DakoCytomation) and a secondary sheep anti-rabbit Ab (Sigma) were used. Samples were analyzed by standard and confocal immunofluorescence microscopy.
Naphtyl acetate esterase staining
Cover slides were fixed in formol vapor for 4 min, incubated for 2 h in the dark, and stained for 2 h in 0.2 mol/L phosphate buffer with 0.5% sodium nitrate solution, 0.5% pararosanilin solution, and 0.3% ␣-naphtyl acetate. After that, cover slides were washed in Aqua dest, stained for 10 min in Mayers Hemalaun solution, and for 15 min in tap water. Naphtyl acetate esterase (NSE) is specific for monocytes, macrophages, megakaryocytic cells, and platelets.
May-Gruenwald staining
CD34
ϩ cells coincubated with platelets for 10 days on cover slides were stained with May-Gruenwald solution (Merck) for 5 min. After removal of supernatants, cells were incubated with Giemsa solution for 20 min, followed by incubation with buffer after "Weise" pH 6.8 (Merck) for another 2 min. Cover slides were analyzed by standard microscopy.
Sudan red staining
Cells were washed with PBS before each incubation step, fixed with 2% formaldehyde solution (20 min), and incubated with 0.5% Sudan red (Sigma; 20 min). Nuclei were counterstained with hematoxyline solution (Sigma) for 5 min and analyzed by standard microscopy.
Platelet phagocytosis
To visualize phagocytosis of platelets by foam cells, platelets were labeled with fluorochrome celltracker tm orange CMTMR and coincubated with CD34 ϩ cells for 7 days in chamber slides. For LDL binding on platelets, platelets were incubated with Dil-AcLDL (red) and Mepacrine (green) for 4 h. Cells were then analyzed by flow cytometry and by standard and confocal fluorescence microscopy.
Scanning and transmission electron microscopy (TEM)
For scanning electron microscopy (SEM), CD34 ϩ cells were cultivated on coverslips in the absence or presence of platelets (2ϫ10 8 cells/ml) for 10 days. Thereafter, the cells were washed twice with PBS, and the coverslips were fixed and examined using a field emission scanning electron microscope (JSM-6300F, Jeol Ltd., Tokyo, Japan). For TEM, CD34 ϩ cells were coincubated with isolated platelets (2ϫ10 8 /ml) for 10 days in culture medium. Subsequently, cells were washed and fixed with glutaraldehyde (2.5%) and tannin (0.02%) in a sodium cacodylate buffer (pH 7.4) before EM was performed (3).
Data presentation and statistics
Comparisons between group means were performed using Student's t test or ANOVA, where applicable. Data are presented as mean Ϯ sd. P Յ 0.05 was considered statistically significant.
RESULTS
Human CD34
؉ cells adhere to immobilized platelets
Recently we showed that adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells (7). To determine the molecular requirements of adhesion of human adult CD34 ϩ cells to platelets, we performed experiments with human CD34 ϩ cells isolated from cord blood. Isolated platelets (2ϫ10 8 /ml) were allowed to adhere to collagen-coated 96-well plates and adhesion of CD34 ϩ cells was evaluated under static conditions, as described (7). We found that human CD34 ϩ cells adhere to immobilized platelets but not to immobilized collagen type I alone, which represents the major extracellular matrix component of the injured arterial wall (Fig. 1) . Adhesion of CD34 ϩ cells to immobilized platelets that were activated by adherence to collagen was significantly atten-uated in the presence of blocking mAbs anti-CD162 or anti-CD62P, indicating that the platelet P-selectin interacts with the EPCs P-selectin glycoprotein ligand-1. Moreover, preincubation of CD34 ϩ with the blocking monoclonal antibodies to ␣ 4 -integrin (CD49d) or to ␤ 2 -integrin (CD18) resulted in a significant decrease of adherent CD34
ϩ to immobilized platelets suggesting that both ␤ 1 -and ␤ 2 -integrins located on the surface of EPCs are involved in the adhesion process between these two types of human cells (Fig. 1 ).
Platelets induce distinct morphological changes of human CD34
؉ cells and differentiate the subpopulations of these progenitor cells into foam and endothelial cells in vitro Next we asked whether CD34 ϩ cells differentiate in the presence of platelets. Human CD34 ϩ progenitor cells were isolated from umbilical cord blood and coincubated (50,000 cells) with isolated human platelets (2ϫ10 8 /ml). After coincubation with platelets for 5-10 days, CD34 ϩ cells underwent substantial morphological changes. About one-third of the cells showed a 3-fold increase in size with round morphology, high granularity, and a diameter of ϳ25 m (Fig. 2A) . No change in morphology of CD34 ϩ cells could be seen during the observation period when platelets were absent ( Fig.  2A) . To further characterize the granular cells, we performed May-Gruenwald, NSE staining, and CD68 immunostaining of the cultured cells. May-Gruenwald staining revealed a nonsegmented nucleus surrounded with a large cytoplasm with enhanced granularity (Fig.  2B ). These cells were positive for NSE and CD68, indicating differentiation into the macrophage/monocytic lineage (Fig. 2B) . To further characterize the intracellular granules, Sudan red III staining was performed, which was found to be positive for these large cells (Fig. 2B) . This indicates that a subpopulation of human CD34 ϩ cells transform into large granular and lipid-rich cells, a morphology typical for foam cells.
Since platelets play a critical part in the capture and ϩ EPCs to immobilized platelets. Under static conditions, EPCs adhere to immobilized platelets via P-selectin/PSGL-1 interaction and ␤ 1 -and ␤ 2 -integrins. 96-well plates precoated with collagen type I (10 g/ml) were incubated with or without freshly isolated platelets in order to achieve an adherent platelet layer as described in Materials and Methods. Human EPCs (20,000 CD34 ϩ cells/well) were allowed to adhere to these platelets for 1 h. Where indicated, CD34
ϩ progenitor cells or platelets were preincubated for 30 min with blocking mAbs, then the plates were gently washed twice. The adherent EPCs were quantified by direct phase contrast microscopy. The mean of 8 independent experiments is shown. Preincubation with blocking mAbs against CD62P, CD162, CD49d, and CD18 reduces the adhesion of EPCs to immobilized platelets. *P Յ 0.05 compared with positive control (immobilized platelets). subsequent differentiation of murine EPCs (7), in the present work we found a subgroup of cells that revealed a spindle-shaped morphology and were positive for vWF (Fig. 3A) . Moreover, these cells had a substantially developed cytoskeleton characteristic of endothelial cells, but not progenitor cells, as verified by phalloidin staining (Fig. 3A) . To further evaluate the role of platelets for differentiation of CD34 ϩ cells into endothelial cells, we cultivated isolated CD34 ϩ cells on immobilized platelets and on immobilized fibronectin or plastic in endothelial cell growth medium. After 5 days the morphology of initially round-shaped CD34 ϩ cells on immobilized platelets turned into adherent spindle-shaped cells that were positive for vWF (Fig.  3B) . Further, CD34
ϩ cells formed colonies on immobilized platelets similar to immobilized fibronectin, indicating differentiation into endothelial cells (Fig. 3B) . In contrast, virtually no colonies were formed on plastic (Fig. 3B) . The number of colonies formed on immobilized platelets was significantly higher compared with plastic wells (number of colonies/10 6 cells, meanϮsd: 38.4Ϯ7.17 platelets vs. plastic 6.63Ϯ8.78, PՅ0.05) (Fig.  3B) . Moreover, CD34
ϩ cells cultivated on immobilized platelets were positive for the endothelial markers CD146 and CD31 (Fig. 3C) .
Phagocytosis of platelets is involved in foam cell generation derived from CD34
؉ progenitor cells
As shown above, platelets induced foam cell generation derived from a subpopulation of human CD34 ϩ progenitor cells in vitro (Fig. 4A, B) . Phase contrast microscopy showed that these foam cells are surrounded by a platelet-free zone, indicating enhanced phagocytotic activity of these cells (Fig. 4A, Supplemental Movie 1) . TEM of the foam cells revealed the presence of multiple vesicles with phagocytosed platelets or platelet fragments (Fig. 4B) . Next we asked whether platelets are internalized into macrophages/foam cells. Therefore, platelets were labeled with cell tracker orange and added to the platelet/CD34 ϩ coculture (Fig. 4C) . Internalization of platelets occurred rapidly, and after 24 h a substantial number of platelets were internalized by foam cells (Fig. 4C) .
Uptake of modified LDL by macrophages plays an important role in the formation of foam cells, the early step of atherosclerosis (17) . Platelets bind LDL, which in turn leads to enhanced platelet responsiveness (18) . Therefore, we asked whether platelets mediate LDL uptake into foam cells. To visualize LDL binding, platelets were incubated with the fluorochrome-conjugated acetylated LDL (Dil-AcLDL) (red) and with mepacrine (green), which specifically accumulates in dense granules of platelets. We found that platelets bound and internalized substantial amounts of DilAcLDL, as verified by fluorescence microscopy and flow cytometry (Fig. 5A) . When Dil-AcLDL-labeled platelets were added to the platelet/CD34 ϩ coculture, a significant uptake of LDL-positive platelets into foam cells was observed (Fig. 5B) , whereas virtually no uptake of LDL-labeled platelets was observed in cells that did not differentiate into foam cells (Fig. 5B) . 
Inhibitors of HMG coenzyme A reductase (statins) reduce platelet-induced foam cell generation
HMG coenzyme A reductase inhibitors (statins) are potent drugs for the prevention of atherosclerotic disease. It is increasingly being recognized that statins reduce atheroprogression beyond mere lipid-lowering effects (19) . Therefore, we evaluated the effect of various statins on platelet-mediated foam cell generation in vitro. We found that all compounds tested, including pravastatin, simvastatin, fluvastatin, and atorvastatin, substantially reduced platelet-mediated foam cell formation (Fig. 6A, B) . Pravastatin, however, was less potent in inhibiting platelet-mediated foam cell formation than the other compounds tested (Fig. 6A,  B) . Statins have been shown to reduce secretion of MMPs from vascular cells, implying an antiatherosclerotic pleiotropic effect of these compounds (20) . To evaluate the effect of statins on secretion of MMPs in our cocultures, CD34 ϩ cells were cocultured with platelets in the absence and presence of various statins. We found that all tested statins substantially reduced MMP-9 activity in the culture supernatant (Fig. 6C) . Again, as noted above for foam cell generation, the inhibitory effect of pravastatin was less pronounced than that of simvastatin, fluvastatin, or atorvastatin (Fig. 6C) .
Inhibition of platelet-mediated foam cell formation from CD34 ؉ cells and secretion of matrix metalloproteinase-9 by PPAR agonists
Peroxisome proliferator-activated receptors are nuclear receptors that regulate lipid and Glc metabolism as well as cellular differentiation (17) . Agonists of PPARs have been found to reduce foam cell generation both in vitro (21) and in vivo (22) . To investigate the potential importance of PPAR on platelet-mediated foam cell generation, we performed a systematic analysis of the effects of various PPAR-␣ (fenofibrate, WY14643) and -␥ (troglitazone, GW1929) agonists. Both types of PPAR agonists reduced platelet-mediated foam cell formation (Fig. 7) . A less pronounced reduction in foam cell generation was observed in the presence of PPAR-␣ agonists compared with PPAR-␥ agonists (Fig. 7) . In concert with their effects on foam cell generation, PPAR-␣ and PPAR-␥ agonists inhibited MMP-9 activity of the cell culture supernatant (Fig. 7) . However, peptide MMP inhibitor GM6001, applied in different concentrations (1 and 20 g/ml), did not attenuate foam cell generation (data not shown).
DISCUSSION
In this study we show that platelets regulate recruitment and transformation of foam cells and endothelial cells out of CD34 ϩ progenitor cells. The major findings of the present study are 1) collagen-adherent platelets recruit CD34 ϩ progenitor cells via specific adhesion receptors, including P-selectin/PSGL-1, ␤ 1 -, and ␤ 2 -integrins; 2) collagen-adherent and thereby activated These findings imply that interaction of platelets with circulating progenitor cells is important for repair mechanisms at the site of vascular lesions. It is tempting to speculate that an altered balance of platelet-mediated transformation of CD34 ϩ progenitor cells into macrophages/foam cells and endothelial cells may play a critical role in atherogenesis and atheroprogression. Understanding and modulating these mechanisms may be a promising way to treat patients at high risk for atherosclerotic diseases.
The maintenance of vascular integrity is crucial for preventing atheroprogression. Circulating progenitor cells have been shown to instigate new vessel formation via angiogenesis and neovascularization but also have the potential to provide ongoing vascular repair by homing to site of vascular damage (5) . However, the mechanisms that recruit circulating progenitor cells toward vascular lesions and regulate repair mechanisms are not understood completely. Platelets are the first circulating blood cells that interact with the injured vessel wall; they accumulate within seconds to sites of vascular injury and release a variety of potent chemotactic factors (e.g., SDF-1␣) (23, 24) . Thus, platelets induce recruitment of circulating blood cells, including progenitor cells toward sites of vessel injury. Here we show that human EPCs-these are still Ͼ98% positive for CD34
ϩ -adhere to immobilized platelets via Pselectin/PSGL-1 and ␤ 1 -and ␤ 2 -integrins. In the present study we focused on the potential role of platelets in the CD34 ϩ transformation. When adherent human CD34 ϩ were cocultivated with platelets for 1 wk, we found that a substantial number of CD34 ϩ cells (ϳone-third) transform into foam cells.
Foam cell generation from macrophages with subsequent fatty streak formation plays a key role in early atherogenesis (17) . Foam cell formation is thought to be induced by low density lipoproteins (LDL), including oxidized LDL (OxLDL) or minimally modified LDL (mmLDL) (17) . LDL binds to and activates platelets (25) . We found that modified LDL (Dil-AcLDL) is taken up by platelets and stored specifically in mepacrine-containing organelles, thus in dense granules. Moreover, we demonstrate that platelets labeled with Dil-AcLDL are rapidly internalized into foam cells, as shown by electron and fluorescence microscopy. Thus, platelets may be a major vehicle for LDL, and phagocytosis of platelet/LDL may be a critical step during foam cell generation. This conclusion is supported by recent findings showing substantial platelet phagocytosis of macrophages both in vitro and in vivo (26, 27) .
Anti-inflammatory pleiotropic effects of statins are increasingly recognized to play a central role in the antiatherosclerotic activities of these drug compounds (19) . Statins lower the expression and function of (MMPs in atherogenic cells, including macrophages, a major source of MMPs in lesions (19) . Platelets have been shown to induce secretion of MMP-9 by monocytes (28) . We found that all statins tested reduced platelet-induced foam cell generation derived from CD34 ϩ progenitor cells. Moreover, we found that the reduction of foam cell generation was paralleled by reduced secretion of MMP-9, a proteinase critically involved in foam cell generation and atheroprogression (20, 29, 30) . PPAR-␣ and -␥ regulate the expression of MMPs (31) . We demonstrate that PPAR-␣ and -␥ agonists reduce MMP-9 secretion and foam cell generation. Thus, we conclude that MMP-9 may play a critical part in platelet-mediated foam cell generation derived from progenitor cells. However, a MMP inhibitor did not attenuate foam cell generation. We cannot at this time provide direct evidence that platelet-mediated recruitment and differentiation of progenitor cells into foam cells and endothelial cells play a critical physiological or pathophysiological role in humans. However, only recently we found that platelets recruit EPCs to vascular lesions in mice in vivo (23) . Platelet-mediated progenitor cell recruitment may help repair mechanisms at endothelial lesions and may favor regeneration of vascular lesions. Under pathophysiological conditions, CD34
ϩ may undergo transformation in the presence of activated platelets. The balance between platelet-mediated endothelial cell regeneration and foam cells generation derived from CD34 ϩ EPCs may determine the degree and progression of atherosclerosis (Fig. 8) . 
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SPECIFIC AIMS
Beyond their role in hemostasis and thrombosis, platelets play a critical role in atherogenesis. They interact with the endothelium and induce alterations of chemotactic and adhesive properties of endothelial cells, a critical step in atherogenesis. The aim of this study was to evaluate the effect of platelets on recruitment and differentiation of human CD34 ϩ progenitor cells into foam cells and endothelial cells. We demonstrate a potentially important mechanism that regulates the balance of vascular repair mechanisms and atherogenesis.
PRINCIPAL FINDINGS
Human CD34 ؉ cells adhere to immobilized platelets under static conditions
To determine the molecular requirements of adhesion of human adult CD34 ϩ cells to platelets, we performed experiments with human CD34 ϩ cells isolated from cord blood. We found that human CD34 ϩ cells adhere to immobilized platelets but not to immobilized collagen type I alone, which represents the major extracellular matrix component of the injured arterial wall. Adhesion of CD34 ϩ cells to immobilized platelets was significantly attenuated in the presence of blocking mAbs anti-CD162 or anti-CD62P, indicating that the platelet P-selectin interacts with the endothelial progenitor cell (EPC), P-selectin glycoprotein ligand-1. Moreover, preincubation of CD34 ϩ with blocking monoclonal antibodies to ␣ 4 -integrin (CD49d) or to ␤ 2 -integrin (CD18) resulted in a significant decrease of adherent CD34
ϩ to immobilized platelets, suggesting that both ␤ 1 -and ␤ 2 -integrins located on the surface of EPCs are involved in the adhesion process between these two types of human cells (Fig. 1A) .
Platelets induce distinct morphological changes of human CD34
؉ cells and differentiate the subpopulations of these progenitor cells into foam and endothelial cells in vitro Next we asked whether CD34 ϩ cells differentiate in the presence of platelets. After coincubation with platelets for 5-10 days, CD34
ϩ cells underwent substantial morphological changes. About one-third of the cells showed a 3-fold increase in size, with round morphology, high granularity, and a diameter of ϳ 25 m (Fig.  1B) . No change in the morphology of CD34 ϩ cells was observed during the period when platelets were absent. To further characterize the cells, May-Gruenwald staining revealed a nonsegmented nucleus surrounded by a large cytoplasm with enhanced granularity and NSE and CD68 staining, indicating differentiation into the macrophage/monocytic lineage (Fig. 1B) . Moreover, Sudan red III staining indicates that CD34 ϩ cells transform into large granular and lipid-rich cells, comparable to foam cells.
In the present work, we found that CD34 ϩ cells formed colonies on immobilized platelets similar to immobilized fibronectin, indicating transformation into endothelial cells. In contrast, virtually no colonies were formed on plastic (Fig. 1C) . The cells cultivated on immobilized platelets were positive for the endothelial markers CD146 and CD31, but also for von Willebrand factor and phalloidin.
Phagocytosis of platelets is involved in foam cell generation derived from CD34
؉ progenitor cells Uptake of modified LDL by macrophages plays an important role in the formation of foam cells, an early step of atherosclerosis. We were tempted to speculate that platelets bind LDL, so we asked whether platelets mediate LDL uptake into foam cells. We found that platelets bound and internalized substantial amounts of Dil-AcLDL, as verified by fluorescence microscopy and flow cytometry. When Dil-AcLDL-labeled platelets were added to the platelet/CD34 ϩ coculture, a significant uptake of LDL-positive platelets into foam cells was observed, whereas virtually no uptake of LDL-labeled platelets was observed in cells that did not differentiate into foam cells (Fig. 1D) . We found that all compounds tested, including pravastatin, simvastatin, fluvastatin, and atorvastatin, substantially reduced platelet-mediated foam cell formation (Fig. 2) . Pravastatin, however, was less potent in inhibiting plateletmediated foam cell formation than the other compounds ( Fig. 2A) .
We also found that all tested statins substantially reduced MMP-9 activity in the culture supernatant. Again, as noted for foam cell generation, the inhibitory effect of pravastatin was less pronounced than that of simvastatin, fluvastatin, or atorvastatin.
Inhibition of platelet-mediated foam cell formation from CD34
؉ cells and secretion of matrix metalloproteinase-9 by peroxisome proliferator-activated receptor (PPAR) agonists
To investigate the potential importance of PPAR on platelet-mediated foam cell generation, we systematically analyzed the effects of various PPAR-␣ (fenofibrate, WY14643) and -␥ (troglitazone, GW1929) agonists. Both types of PPAR agonists reduced plateletmediated foam cell formation (Fig. 2B) . A less pronounced reduction in foam cell generation was observed in the presence of PPAR-␣ agonists than with PPAR-␥ agonists (Fig. 2B ). In concert with their effects on foam cell generation, PPAR-␣ and PPAR-␥ agonists inhibited MMP-9 activity of the cell culture supernatant.
CONCLUSIONS AND SIGNIFICANCE
In this study we show that platelets regulate recruitment and differentiation of CD34 ϩ progenitor cells into foam cells and endothelial cells. The findings imply that interaction of platelets with circulating progenitor cells is important for repair mechanisms at the site of Foam cell formation from macrophages with subsequent fatty streak formation plays a key role in early atherogenesis and is thought to be induced by low density lipoproteins (LDL), including oxidized LDL or minimally modified LDL. LDL binds to and activates platelets. We found that modified LDL (Dil-AcLDL) is taken up by platelets and stored specifically in mepacrine-containing organelles, thus in dense granules. Moreover, we demonstrated that platelets labeled with Dil-AcLDL are rapidly internalized into foam cells as shown by electron and fluorescence microscopy. Thus, it is tempting to speculate that platelets are a major vehicle for LDL and that phagocytosis of platelet/LDL is a critical step during foam cell generation.
Anti-inflammatory pleiotropic effects of statins are increasingly recognized to play a central role in the antiatherosclerotic activities of these drug compounds. Statins lower the expression and function of matrix metalloproteinases (MMPs) in atherogenetic cells, including macrophages, a major source of MMPs in lesions. Platelets have been shown to induce secretion of MMP-9 by monocytes. We found that all tested statins reduced platelet-induced foam cell generation derived from CD34 ϩ progenitor cells. Moreover, we found that the reduction of foam cell generation was paralleled by a reduced secretion of MMP-9, a proteinase critically involved in foam cell generation and atheroprogression. We also show that agonists of the PPARs ␣ and ␥ (PPARs) regulate expression of MMPs and reduce MMP-9 secretion and foam cell generation. Thus, we conclude that MMP-9 plays a critical part in plateletmediated foam cell generation derived from progenitor cells.
Currently, we cannot provide direct evidence that platelet-mediated recruitment and differentiation of progenitor cells into foam cells and endothelial cells play a critical physiological or pathophysiological role in humans. Nevertheless, only recently we found that platelets recruit EPCs to vascular lesions in mice in vivo (Massberg et al., unpublished results). Platelet-mediated progenitor cell recruitment may help repair mechanisms at endothelial lesions and favor regeneration of vascular lesions. Under pathophysiological conditions, EPCs may undergo differentiation in the presence of activated platelets. The balance between platelet-mediated endothelial cell regeneration and foam cell generation derived from CD34
ϩ EPCs may determine the degree and progression of atherosclerosis.
We show that platelets induce recruitment and differentiation of CD34 ϩ progenitor cells into foam cells and endothelial cells. Thus, it is tempting to speculate that LDL binds to platelets and that phagocytosis of platelet/LDL is a critical step during foam cell generation. Foam cell formation from macrophages with subsequent fatty streak formation affects proatherogenic cells, which could be inhibited by HMG coenzyme A reductase inhibitors (statins) and agonists of PPAR-␣ and -␥. Platelet-mediated progenitor cell recruitment and differentiation into endothelial cell may favor regeneration of vascular lesions and affect antiatherogenic properties. 
